Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors

BMC Genomics

Volumn 15, Issue , 2014, Pages 1-9

  Dhanjal, Jaspreet Kaur ^a   Grover, Sonam ^a   Sharma, Sudhanshu ^b   Singh, Ajeet Kumar ^a   Grover, Abhinav ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b DELHI TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN SALICYLIC ACID; NATURAL PRODUCT; PROTEIN TYROSINE PHOSPHATASE B INHIBITOR; SALICYLIC ACID; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN; BENZOFURAN DERIVATIVE; ENZYME INHIBITOR; MPTPA PROTEIN, MYCOBACTERIUM TUBERCULOSIS; PROTEIN TYROSINE PHOSPHATASE; TUBERCULOSTATIC AGENT;

ALGORITHM; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; IC50; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MODEL; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; MYCOBACTERIUM TUBERCULOSIS; REGRESSION ANALYSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BENZOFURANS; ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MYCOBACTERIUM TUBERCULOSIS; PROTEIN TYROSINE PHOSPHATASES; REGRESSION ANALYSIS;

EID: 84945927166     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-S1-S3     Document Type: Article

References (21)

1. Batsch NL, Mittelman MS: World Alzheimer Report 2012: Overcoming the stigma of dementia. Alzheimer's Disease International 2012.
2. He YXJ, Yu ZH, Gunawan AM, Wu L, Wang L, Zhang ZY: Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold. J Med Chem 2013, 56(3):832-842.
3. Hunter T: The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 1998, 353:583-605.
4. Zhang ZY: Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 2001, 5:416-423.
5. Ventura JJ, Nebreda AR: Protein kinases and phosphatases as therapeutic targets in cancer. Clin Transl Oncol 2006, 8:153-160.
6. Zhou BHY, Zhang X, Xu J, Luo Y, Wang Y, Franzblau SG, Yang Z, Chan RJ, Liu Y, Zheng J, Zhang ZY: Targeting Mycobacterium Protein Tyrosine Phosphatase B for Anti-Tuberculosis Agents. Proc Natl Acad Sci USA 2010, 107:4573-4578.
7. Chen LZB, Zhang S, Wu L, Wang Y, Franzblau SG, Zhang ZY: Identification and characterization of small molecule inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis. ACS Med Chem Lett 2010, 1:355-359.
8. Singh R RV, Shakila H, Gupta R, Khera A, Dhar N, Singh A, Koul A, Singh Y, Naseema M, Narayanan PR, Paramasivan CN, Ramanathan VD, Tyagi AK: Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol 2003, 50:751-762.
9. Beresford NJ MD, Szczepankiewicz B, Liu G, Johnson ME, FordhamSkelton A, Abad-Zapatero C, Cavet JS, Tabernero L: Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages. Journal of Antimicrobial Chemotherapy 2009, 63:928-936.
10. Gandhi NRNP, Dheda K, Schaaf HS, Zignol M, Soolingen DV, Jensen P, Bayona J: Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843.
11. Verma JKV, Coutinho EC: 3D-QSAR in drug design-a review. Curr Top Med Chem 2010, 10(1):95-115.
12. VLifeMDS: Molecular Design Suite. Vlife Sciences Technologies Pvt. Ltd., Pune, India;, 3.0 2004.
13. Acharya CCA, Polli JE, MacKerell AD Jr: Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach. Curr Comput Aided Drug Des 2011, 7(1):10-22.
14. Irwin JJSB: ZINC-a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling 2005, 45:177-182.
15. Grundner CNH, Alber T: Mycobacterium tuberculosis protein tyrosine phosphatase PtpB structure reveals a diverged fold and a buried active site. Structure 2005, 13(11):1625-1634.
16. Stahle L, Ljungberg T, Rodebjer A, Ogren SO, Ungerstedt U: Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat. Pharmacol Toxicol 1987, 60(3):227-232.
17. Schrödinger: Schrödinger Suite 2009: Protein Preparation Wizard; Epik version 2.0, Schrödinger, LLC, New York, NY, 2009; Impact version 5.5, Schrödinger, LLC, New York, NY, 2009; Prime version 2.1, Schrödinger, LLC, New York, NY, 2009. 2009.
18. Halgren TAMR, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL: Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry 2004, 47:1750-1759.
19. Grundner C, Ng HL, Alber T: Mycobacterium tuberculosis protein tyrosine phosphatase PtpB structure reveals a diverged fold and a buried active site. Structure 2005, 13(11):1625-1634.
20. Wallace ACLR: LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995, 8(2):127-134.
21. S. K. Jain, S. Vishwakarma and P. Nayak: 3D QSAR Analysis on Pyrrolidine Derivatives as DPP IV Inhibitors. International Journal of Research in Pharmaceutical and Biomedical Sciences 2011, 2(3):2229-3701.